drugset / Trial / NCT06564740

Stem Cell Applications in Biliary Atresia Patients

NCT06564740

Recruiting 64 enrolled Necmi Kadıoğlu Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Recently, mesenchymal stem cell (MSC) transplantation has emerged as a promising treatment for liver cirrhosis in adults. Additionally, bone marrow-derived stem cell transplantation has shown success in treating children with biliary atresia (BA). This study aims to evaluate the efficacy of Umbilical Cord-Derived Mesenchymal Stem Cell (UC-MSC) therapy in BA through a multicentric randomized controlled trial.

Timeline

Start
2024-06-01
Primary completion
2026-05-30
Completion
2026-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject human umbilical cord mesenchymal stem cells Cell therapy 1e+06 cells/kg Other